ArticleTechnology in cancer research & treatment
EPIDSeg-Net: A Multi-Modal Fusion Framework Based on DRR Guidance in Radiotherapy is Used for Precise Segmentation of MV-EPID Lung Targets.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Radiomics: Current Applications and Future Directions.MedComm · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundBy integrating Digitally Reconstructed Radiograph (DRR) images of pulmonary tumors with Electronic Portal Imaging Device (EPID) images to assist in target segmentation, and subsequently comparing morphological changes in segmented targets across different radiotherapy stages, this approach enables precise quantification of dynamic variations in target volume and shape. This methodological integration provides objective evidence for treatment response evaluation and dynamic optimization of treatment plans, thereby significantly enhancing the precision of radiotherapy delivery.MethodsThe proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture features and a Swin-Transformer branch for capturing global semantic features. The model first calibrates multimodal input features through a Dual Attention Mechanism (DAM) to adaptively adjust modality-specific weights, thereby enhancing tolerance to missing image information in multi-sequence segmentation. Subsequently, two key modules are implemented within the multi-scale feature layer: a Large-Kernel Grouped Attention Gating (LKG-Gate) module to strengthen local contextual awareness, and a Multi-Path Feature Extraction (MPFE) module to improve feature robustness via a parallel structure. These designs enable the model to effectively focus on lung tumor target regions, optimize segmentation accuracy, and achieve high-performance reconstruction.ResultsThe framework effectively integrates multimodal features, enabling high-precision localization and sharp boundary delineation while preserving anatomical details. Quantitative evaluations demonstrate superior performance: DICE = 93.2 (92.4∼93.9), CE = 0.352, HD95 = 9.42 (6.03∼12.8), IOU = 86.0 (84.1∼87.9), and SENCE = 0.828. Overall, the model excels at preserving gradient information, regional integrity, and fine details; effectively suppresses feature loss; and reduces missed segmentation rates, leading to improvements in both subjective and objective performance metrics.ConclusionThe proposed segmentation method effectively integrates information from EPID and DRR images, enabling more precise localization and segmentation of lesion regions within EPID images while enhancing segmentation accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.